{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard first-line treatment for acute inflammatory demyelination To accelerate recovery of vision and motor function Infection markers (CRP, WCC) are normal\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection prophylaxis during high-dose steroid therapy\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Specific diagnosis (MS vs NMOSD) must be confirmed via antibody status and CSF results first Choice of agent depends on the specific underlying pathology\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard first-line treatment for acute inflammatory demyelination\", \"To accelerate recovery of vision and motor function\", \"Infection markers (CRP, WCC) are normal\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection prophylaxis during high-dose steroid therapy\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab)\", \"timing\": \"Delay\", \"reasons\": [\"Specific diagnosis (MS vs NMOSD) must be confirmed via antibody status and CSF results first\", \"Choice of agent depends on the specific underlying pathology\"]}]"
}